CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 40 filers reported holding CONMED CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,610,000 | – | 6,098,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 50,065,000 | $86,599,000 | 6.97% |
| III Capital Management | 12,488,000 | $21,464,000 | 1.87% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,035,000 | $6,946,000 | 1.55% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,082,000 | $10,261,000 | 1.29% |
| SSI INVESTMENT MANAGEMENT LLC | 6,448,000 | $11,078,000 | 0.60% |
| MACKAY SHIELDS LLC | 38,008,000 | $65,472,000 | 0.58% |
| Eisler Capital (UK) Ltd. | 9,500,000 | $16,280,000 | 0.27% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 53,974,000 | $93,024,000 | 0.26% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 2,607,000 | $4,493,000 | 0.25% |
| Polar Asset Management Partners Inc. | 10,000,000 | $17,137,000 | 0.18% |